Health Catalyst, Inc.
HCAT
$3.80
-$0.185-4.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 311.27M | 306.58M | 302.06M | 299.48M | 296.79M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 311.27M | 306.58M | 302.06M | 299.48M | 296.79M |
| Cost of Revenue | 168.28M | 164.79M | 162.59M | 162.10M | 161.53M |
| Gross Profit | 143.00M | 141.79M | 139.47M | 137.38M | 135.27M |
| SG&A Expenses | 96.54M | 100.65M | 103.32M | 107.80M | 111.61M |
| Depreciation & Amortization | 43.23M | 41.43M | 41.47M | 41.68M | 41.75M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 363.97M | 363.68M | 366.31M | 373.96M | 381.02M |
| Operating Income | -52.69M | -57.10M | -64.25M | -74.48M | -84.23M |
| Income Before Tax | -72.22M | -69.17M | -79.29M | -86.06M | -105.14M |
| Income Tax Expenses | 435.00K | 333.00K | -149.00K | 385.00K | 400.00K |
| Earnings from Continuing Operations | -72.66 | -69.50 | -79.14 | -86.45 | -105.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.66M | -69.50M | -79.14M | -86.45M | -105.54M |
| EBIT | -52.69M | -57.10M | -64.25M | -74.48M | -84.23M |
| EBITDA | -19.67M | -25.37M | -32.08M | -41.70M | -51.18M |
| EPS Basic | -1.15 | -1.15 | -1.35 | -1.50 | -1.85 |
| Normalized Basic EPS | -0.57 | -0.59 | -0.62 | -0.70 | -0.82 |
| EPS Diluted | -1.15 | -1.15 | -1.35 | -1.50 | -1.85 |
| Normalized Diluted EPS | -0.57 | -0.59 | -0.62 | -0.70 | -0.82 |
| Average Basic Shares Outstanding | 250.67M | 240.71M | 235.81M | 232.08M | 228.76M |
| Average Diluted Shares Outstanding | 250.67M | 240.71M | 235.81M | 232.08M | 228.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |